Position in RDNT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$801
-$22,031 QoQ
Shares Held
13
-95.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#308
of 327 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Plante Moran Financial Advisors, LLC holds $689,932 across 12 Diagnostics & Research names. RDNT ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,842 | $541,344 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
269 | $134,865 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
9 | $4,766 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
8 | $4,211 | |
| 5 | VCYT |
Veracyte, Inc.
|
24 | $1,409 | |
| 6 | RDNT |
RadNet, Inc.
This page
|
13 | $801 | |
| 7 | A |
Agilent Technologies, Inc.
|
5 | $664 | |
| 8 | QGEN |
Qiagen N.V.
|
17 | $664 |
All Filings in RDNT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $801 | 13 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $22,832 | 320 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||